Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ricardo E Vilain

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Pathology|March 30, 2016
Advances in melanoma: revolutionary progress delivering improved patient management and outcomesRichard A Scolyer, Ricardo E Vilain, Martin C Mihm
Pathology|March 30, 2016
The regenerating naevusRicardo E Vilain, Stanley W McCarthy, Richard A Scolyer
The American Journal of Surgical Pathology|July 15, 2011
"Pediatric-type" gastrointestinal stromal tumors are SDHB negative ("type 2") GISTsAnthony J Gill, Angela Chou, Ricardo E Vilain, et al.
The American Journal of Surgical Pathology|April 15, 2015
BAP1-inactivated spitzoid naeviRicardo E Vilain, Stanley W McCarthy, John F Thompson, et al.
Annals of Surgical Oncology|April 15, 2016
Breslow Thickness Measurements of Melanomas Around American Joint Committee on Cancer Staging Cut-Off Points: Imprecision and Terminal Digit Bias Have Important Implications for Staging and Patient ManagementLudi Ge, Ricardo E Vilain, Serigne Lo, et al.
Medicine|June 23, 2020
Pilot early phase II study of decitabine and carboplatin in patients with advanced melanomaAndre van der Westhuizen, Naomi Knoblauch, Moira C Graves, et al.
Oncotarget|October 22, 2021
Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastomaKelsey Maddison, Moira C Graves, Nikola A Bowden, et al.
Frontiers in Medicine|June 14, 2019
Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker ProfilesMoira Graves, Giovana CelliMarchett, Belinda van Zyl, et al.
Gynecologic Oncology|September 9, 2018
Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancerJames Scurry, Belinda van Zyl, Damien Gulliver, et al.
Oncotarget|August 4, 2016
Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repairTimothy Budden, Ryan J Davey, Ricardo E Vilain, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Pathology|March 30, 2016
Advances in melanoma: revolutionary progress delivering improved patient management and outcomesRichard A Scolyer, Ricardo E Vilain, Martin C Mihm
Pathology|March 30, 2016
The regenerating naevusRicardo E Vilain, Stanley W McCarthy, Richard A Scolyer
The American Journal of Surgical Pathology|July 15, 2011
"Pediatric-type" gastrointestinal stromal tumors are SDHB negative ("type 2") GISTsAnthony J Gill, Angela Chou, Ricardo E Vilain, et al.
The American Journal of Surgical Pathology|April 15, 2015
BAP1-inactivated spitzoid naeviRicardo E Vilain, Stanley W McCarthy, John F Thompson, et al.
Annals of Surgical Oncology|April 15, 2016
Breslow Thickness Measurements of Melanomas Around American Joint Committee on Cancer Staging Cut-Off Points: Imprecision and Terminal Digit Bias Have Important Implications for Staging and Patient ManagementLudi Ge, Ricardo E Vilain, Serigne Lo, et al.
Medicine|June 23, 2020
Pilot early phase II study of decitabine and carboplatin in patients with advanced melanomaAndre van der Westhuizen, Naomi Knoblauch, Moira C Graves, et al.
Oncotarget|October 22, 2021
Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastomaKelsey Maddison, Moira C Graves, Nikola A Bowden, et al.
Frontiers in Medicine|June 14, 2019
Monitoring Patient Response to Pembrolizumab With Peripheral Blood Exhaustion Marker ProfilesMoira Graves, Giovana CelliMarchett, Belinda van Zyl, et al.
Gynecologic Oncology|September 9, 2018
Nucleotide excision repair protein ERCC1 and tumour-infiltrating lymphocytes are potential biomarkers of neoadjuvant platinum resistance in high grade serous ovarian cancerJames Scurry, Belinda van Zyl, Damien Gulliver, et al.
Oncotarget|August 4, 2016
Repair of UVB-induced DNA damage is reduced in melanoma due to low XPC and global genome repairTimothy Budden, Ryan J Davey, Ricardo E Vilain, et al.
Pageof 3